by Chandré Blignaut | Oct 21, 2020 | Featured, JEMDSA, SAGP, SAPJ
SA’s leading provider of CVS medicine launches two new valsartan products Pharma Dynamics, the country’s leading supplier of cardiovascular medicine, has introduced Regoval (valsartan) and Regoval Co (valsartan/hydrochlorothiazide). Valsartan is an angiotensin...
by Chandré Blignaut | Oct 20, 2020 | Featured, News, SAGP, SAPA, SAPJ
Is your child’s gut health up to scratch? We are already well into spring, many of our children are going back to school after a long period of staying at home and we are in the midst of a very unsettling and unusual time with the world shaken by the COVID-19...
by Chandré Blignaut | Oct 9, 2020 | Featured, SAGP, SAPA
New supplement launched in SA to assist with male infertility For many couples, starting a family happens naturally without any detailed planning or interventions. Unfortunately, when trying to conceive, 15% of couples struggle and may need to seek medical advice...
by Chandré Blignaut | Sep 29, 2020 | Featured, News, SAGP
Excessive salt consumption taking its toll on South Africans’ hearts The country’s biggest provider of heart disease medication warns South Africans to cut back on salt, as it could have a destructive impact on their cardiovascular system. Nicole Jennings,...
by Chandré Blignaut | Sep 3, 2020 | Featured, News, SAGP
Raising a red flag about angina – an under-recognised and under-treated disorder Johannesburg, 3 September 2020: The burden of cardiovascular disease continues to grow in South Africa.1 The age-standardised death rates for non-communicable diseases (NCDs) in South...
by Chandré Blignaut | Jul 27, 2020 | Featured, News, SAGP, SAJS, SAPJ, WHSA
New affordable broad-spectrum IV antibiotic launched to treat SA’s critically ill South African hospitals will be given a wider choice of high-quality generic intravenous (IV) treatments at a much lower cost – the savings of which will benefit not only SA’s struggling...
